Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemuteporfin PDT in healthy volunteers and mild acne
NCT01490736Phase 2Completed
- Sponsor
- Dermira, Inc.
- Start
- Dec 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lemuteporfin in acne vulgaris, sponsored by Dermira, Inc. Primary endpoint: Change in sebum excretion rate at 14 days. Started Dec 2011; status: completed.
02
Drugs
lemuteporfin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01490736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490736.